Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall Y Chan

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
JAMA Network Open|March 2, 2026
Social Risk Prevalence in Adolescent and Young Adult Patients With and Without a History of CancerCarol Y Ochoa-Dominguez, David M Mosen, Kimberly A Miller, et al.
Acta Haematologica|July 20, 2021
Post-Chemotherapy Histiocyte-Rich Pseudotumors: Radiologic and Endoscopic Mimics of Residual LymphomaMaximilian Goebel, Russell K Brynes, David C Yau, et al.
Cancer Causes & Control : CCC|November 17, 2022
Barriers and facilitators of Hispanic/Latino parents caregiving for a childhood cancer survivor: a qualitative studyCarol Y Ochoa, Randall Y Chan, Lissette Cervantes, et al.
Pediatric Blood & Cancer|February 21, 2022
Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institutionSebastian de Armas, Carolina Huertas-Ayala, Randall Y Chan, et al.
Oncoimmunology|January 25, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastomaSoheila Shirinbak, Randall Y Chan, Shilpa Shahani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 25, 2025
Factors influencing engagement in survivorship care among young adult survivors of hematologic malignancies: a mixed methods reportMelissa P Beauchemin, Rachel Murphy-Banks, Angie Mae Rodday, et al.
JCO Oncology Practice|December 12, 2025
Cancer-Related Impacts on Employment and Strategies for Support Among Long-Term Young Adult Survivors of Hematologic MalignanciesTimothy J D Ohlsen, Rachel Murphy-Banks, Melissa P Beauchemin, et al.
Oncotarget|December 7, 2017
Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYCMichael D Hadjidaniel, Sakunthala Muthugounder, Long T Hung, et al.
JCO Oncology Practice|June 16, 2025
"Nothing Is as Great a Learning Experience as Getting a $15,000 Bill": A Mixed-Methods Study of Young Adult Cancer Survivors' Experience With Insurance CoverageDaniel J Zheng, Rachel Murphy-Banks, Angie Mae Rodday, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
JAMA Network Open|March 2, 2026
Social Risk Prevalence in Adolescent and Young Adult Patients With and Without a History of CancerCarol Y Ochoa-Dominguez, David M Mosen, Kimberly A Miller, et al.
Acta Haematologica|July 20, 2021
Post-Chemotherapy Histiocyte-Rich Pseudotumors: Radiologic and Endoscopic Mimics of Residual LymphomaMaximilian Goebel, Russell K Brynes, David C Yau, et al.
Cancer Causes & Control : CCC|November 17, 2022
Barriers and facilitators of Hispanic/Latino parents caregiving for a childhood cancer survivor: a qualitative studyCarol Y Ochoa, Randall Y Chan, Lissette Cervantes, et al.
Pediatric Blood & Cancer|February 21, 2022
Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institutionSebastian de Armas, Carolina Huertas-Ayala, Randall Y Chan, et al.
Oncoimmunology|January 25, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastomaSoheila Shirinbak, Randall Y Chan, Shilpa Shahani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 25, 2025
Factors influencing engagement in survivorship care among young adult survivors of hematologic malignancies: a mixed methods reportMelissa P Beauchemin, Rachel Murphy-Banks, Angie Mae Rodday, et al.
JCO Oncology Practice|December 12, 2025
Cancer-Related Impacts on Employment and Strategies for Support Among Long-Term Young Adult Survivors of Hematologic MalignanciesTimothy J D Ohlsen, Rachel Murphy-Banks, Melissa P Beauchemin, et al.
Oncotarget|December 7, 2017
Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYCMichael D Hadjidaniel, Sakunthala Muthugounder, Long T Hung, et al.
JCO Oncology Practice|June 16, 2025
"Nothing Is as Great a Learning Experience as Getting a $15,000 Bill": A Mixed-Methods Study of Young Adult Cancer Survivors' Experience With Insurance CoverageDaniel J Zheng, Rachel Murphy-Banks, Angie Mae Rodday, et al.
Pageof 3